27 October 2021>: Clinical Research
Accuracy of Continuous and Noninvasive Hemoglobin Monitoring in the Presence of CO Insufflation: An Observational Pilot Study
Hye Sun Lee 1C* , Ji Won Yoo 2ADE* , Ha Yeon Kim 3BD , Na Young Kim 3B , Ji Eun Kim 3ABDEF*DOI: 10.12659/MSM.933027
Med Sci Monit 2021; 27:e933027
Table 1 Patient’s characteristics and operational data.
n=20 | |
---|---|
Age (years) | 54 (49–70) |
Height (cm) | 161.8±9.6 |
Weight (kg) | 69.6±14.7 |
Gender (Male/Female) | 12/8 |
ASA physical status (1/2/3) | 8/8/4 |
Diabetes | 6 (30%) |
Crystalloid (mL) | 1100 (600–1525) |
Colloid (mL) | 500 (450–500) |
Packed RBC (unit) | 0 (0–0) |
Urine (mL) | 160 (115–260) |
Bleeding (mL) | 100 (50–100) |
Total dose of remifentanil (ug) | 900 (660–1200) |
Total dose of rocuronium (mg) | 110 (85–150) |
Operation time (min) | 160 (133–213) |
Anesthesia time (min) | 218.8±62.5 |
Pneumoperitoneum time (min) | 100 (145–185) |
Values are presented as mean±standard deviation, median (interquartile range) or number (%). ASA – American Society of Anesthesiologists; RBC – red blood cell. |